Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incident diabetes in course of antiretroviral therapy.
Taramasso L, Squillace N, Ricci E, Menzaghi B, Orofino G, Socio GV, Molteni C, Martinelli CV, Madeddu G, Vichi F, Valsecchi L, Celesia BM, Maggi P, Rusconi S, Pellicanò GF, Cascio A, Sarchi E, Gulminetti R, Falasca K, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. Among authors: bonfanti p. AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14. AIDS. 2023. PMID: 36927963
Risk factors for lipodystrophy in the CISAI cohort.
Bonfanti P, Gulisano C, Ricci E, Timillero L, Valsecchi L, Carradori S, Pusterla L, Fortuna P, Miccolis S, Magnani C, Gabbuti A, Parazzini F, Martinelli C, Faggion I, Landonio S, Quirino T, Vigevani G; Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. Bonfanti P, et al. Biomed Pharmacother. 2003 Nov;57(9):422-7. doi: 10.1016/j.biopha.2003.06.002. Biomed Pharmacother. 2003. PMID: 14652168 Clinical Trial.
An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir.
Bonfanti P, Martinelli C, Ricci E, Carradori S, Parruti G, Armignacco O, Magnani C, Quirino T; CISAI Group (Italian Coordinators for the Study of Allergies HIV Infection). Bonfanti P, et al. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):317-20. doi: 10.1097/01.qai.0000164248.56722.3c. J Acquir Immune Defic Syndr. 2005. PMID: 15980692
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].
Madeddu G, Quirino T, Carradori S, Ricci E, Grosso C, Penco G, De Socio G, Rossella E, Palvarini L, Marconi P, Melzi S, Mura MS, Bonfanti P; Gruppo CISAI. Madeddu G, et al. Among authors: bonfanti p. Infez Med. 2006 Sep;14(3):125-34. Infez Med. 2006. PMID: 17127826 Free article. Review. Italian.
HIV and metabolic syndrome: a comparison with the general population.
Bonfanti P, Giannattasio C, Ricci E, Facchetti R, Rosella E, Franzetti M, Cordier L, Pusterla L, Bombelli M, Sega R, Quirino T, Mancia G. Bonfanti P, et al. J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):426-31. doi: 10.1097/QAI.0b013e318074ef83. J Acquir Immune Defic Syndr. 2007. PMID: 17514013
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.
Madeddu G, Bonfanti P, De Socio GV, Carradori S, Grosso C, Marconi P, Penco G, Rosella E, Miccolis S, Melzi S, Mura MS, Landonio S, Ricci E, Quirino T; CISAI Group. Madeddu G, et al. Among authors: bonfanti p. Biomed Pharmacother. 2008 Jan;62(1):6-11. doi: 10.1016/j.biopha.2007.04.008. Epub 2007 May 29. Biomed Pharmacother. 2008. PMID: 17574807
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
De Socio GV, Parruti G, Quirino T, Ricci E, Schillaci G, Adriani B, Marconi P, Franzetti M, Martinelli C, Vichi F, Penco G, Sfara C, Madeddu G, Bonfanti P; CISAI study group. De Socio GV, et al. Among authors: bonfanti p. J Infect. 2008 Jul;57(1):33-40. doi: 10.1016/j.jinf.2008.03.007. Epub 2008 Apr 24. J Infect. 2008. PMID: 18436307
354 results